Synthesis and antibacterial activity of acylides (3-O-acyl-erythromycin derivatives):: A novel class of macrolide antibiotics

被引:52
作者
Tanikawa, T
Asaka, T
Kashimura, M
Misawa, Y
Suzuki, K
Sato, M
Kameo, K
Morimoto, S
Nishida, A
机构
[1] Taisho Pharmaceut Co Ltd, Med Res Labs, Omiya, Saitama 3308530, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Inage Ku, Chiba 2638522, Japan
关键词
D O I
10.1021/jm015566s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction of an acyl group to the 3-O-position of erythromycin A derivatives instead of L-cladinose led to a novel class of macrolide antibiotics that we named "acylides". The 3-O-nitrophenylacetyl derivative TEA0777 showed significantly potent activity against not only erythromycin-susceptible Gram-positive pathogens but also inducibly macrolides-lincosamides-streptogramin B (MLSB)-resistant Staphylococcus aureus and efflux-resistant Streptococcus pneumoniae. These results indicated that acylides have potential as next-generation macrolide antibiotics.
引用
收藏
页码:4027 / 4030
页数:4
相关论文
共 23 条
[1]   Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives):: A new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens [J].
Agouridas, C ;
Denis, A ;
Auger, JM ;
Benedetti, Y ;
Bonnefoy, A ;
Bretin, F ;
Chantot, JF ;
Dussarat, A ;
Fromentin, C ;
D'Ambrières, SG ;
Lachaud, S ;
Laurin, P ;
Le Martret, O ;
Loyau, V ;
Tessot, N .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) :4080-4100
[2]  
AGOURIDAS C, 1992, Patent No. 487411
[3]  
[Anonymous], 37 INT C ANT AG CHEM
[4]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[5]  
ASAKA T, 1997, Patent No. 5591837
[6]  
ASAKA T, 1997, Patent No. 5631354
[7]  
ASAKA T, 1997, Patent No. 5631355
[8]  
ASAKA T, 1995, 35 INT C ANT AG CHEM
[9]  
Asaka T., 1997, US Pat., Patent No. 5602239
[10]  
Asaka T., 1996, US Patent, Patent No. [US5523399A, 5523399]